Aggressive Angiomyxoma of the Vulva and Bladder

Obstet Gynecol. 2017 Oct;130(4):885-888. doi: 10.1097/AOG.0000000000002254.

Abstract

Background: Aggressive angiomyxoma is a rare, locally infiltrative tumor, frequently occurring in female patients. Although wide local excision is considered standard therapy, radical surgery may be needed.

Case: A 49-year-old woman presented with an aggressive angiomyxoma involving the vulva and bladder. Given the hormone receptor status and size of the tumor, the patient was initially treated with fulvestrant and goserelin acetate in an attempt to reduce the size of the mass. She was followed up at 1- to 3-month intervals; after 6 months of treatment, owing to increasing size of the mass and worsening symptoms, the decision was made to proceed with radical surgery.

Conclusion: Although a less radical surgical approach is preferred, radical surgery is possible for treatment of aggressive angiomyxoma when needed.

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Agents, Hormonal / administration & dosage
  • Diagnosis, Differential
  • Estradiol / administration & dosage
  • Estradiol / analogs & derivatives
  • Female
  • Fulvestrant
  • Goserelin / administration & dosage
  • Humans
  • Middle Aged
  • Myxoma / diagnosis*
  • Myxoma / drug therapy
  • Myxoma / surgery
  • Neoadjuvant Therapy
  • Neoplasm Invasiveness
  • Urinary Bladder Neoplasms / diagnosis*
  • Urinary Bladder Neoplasms / drug therapy
  • Urinary Bladder Neoplasms / surgery
  • Vulvar Neoplasms / diagnosis*
  • Vulvar Neoplasms / drug therapy
  • Vulvar Neoplasms / surgery

Substances

  • Antineoplastic Agents, Hormonal
  • Goserelin
  • Fulvestrant
  • Estradiol